Meridian Contrarian Fund

Holding/activity history for  Neurocrine Biosciences Inc. (NBIX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2018   Q3 0 0 Sell 100.00% 1.69
2018   Q2 109,022 1.69 Reduce 9.16% 0.17 $98.24
2018   Q1 120,022 1.63 Reduce 13.67% 0.26 $82.93
2017   Q4 139,022 1.76 $77.59
2017   Q3 139,022 1.47 $61.28
2017   Q2 139,022 1.18 $46.00
2017   Q1 139,022 1.15 Add 16.80% 0.17 $43.30
2016   Q4 119,022 0.88 $38.70
2016   Q3 119,022 1.19 $50.64
2016   Q2 119,022 1.08 $45.45
2016   Q1 119,022 0.93 $39.55
2015   Q4 119,022 1.23 $56.57
2015   Q3 119,022 0.88 Reduce 32.34% 0.42 $39.79
2015   Q2 175,906 1.35 Reduce 32.45% 0.65 $47.76
2015   Q1 260,410 1.59 Reduce 37.97% 0.97 $39.71
2014   Q4 419,800 1.46 Reduce 20.39% 0.37 $22.34
2014   Q3 527,300 1.26 Add 2.93% 0.04 $15.67
2014   Q2 512,300 1.08 Add 15.64% 0.15 $14.84
2014   Q1 443,000 0.99 Add 14.18% 0.12 $16.10
2013   Q4 388,000 0.49 Buy 0.49 $9.34